271 related articles for article (PubMed ID: 7700910)
1. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
Cashman JD; Eaves AC; Wolpe S; Eaves CJ
Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
[No Abstract] [Full Text] [Related]
2. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
[TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
[TBL] [Abstract][Full Text] [Related]
4. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of anti-tumor cytotoxic effectors.
Verma UN; Bagg A; Brown E; Mazumder A
Bone Marrow Transplant; 1994 Feb; 13(2):115-23. PubMed ID: 8205079
[TBL] [Abstract][Full Text] [Related]
6. A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors.
Youn BS; Jang IK; Broxmeyer HE; Cooper S; Jenkins NA; Gilbert DJ; Copeland NG; Elick TA; Fraser MJ; Kwon BS
J Immunol; 1995 Sep; 155(5):2661-7. PubMed ID: 7650394
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
Skala JP; Rogers PC; Chan KW; Rodriguez WC
Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
[No Abstract] [Full Text] [Related]
8. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.
Graham GJ; Wright EG; Hewick R; Wolpe SD; Wilkie NM; Donaldson D; Lorimore S; Pragnell IB
Nature; 1990 Mar; 344(6265):442-4. PubMed ID: 2320111
[TBL] [Abstract][Full Text] [Related]
9. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
Eaves CJ; Cashman JD; Wolpe SD; Eaves AC
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12015-9. PubMed ID: 8265663
[TBL] [Abstract][Full Text] [Related]
10. Long-term culture of chronic myeloid leukemia (CML) bone marrow cells.
Santucci MA; Zaccaria A; Testoni N; Russo D; Zuffa E; Baccarani M; Tura S
Haematologica; 1991; 76(5):357-62. PubMed ID: 1806437
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
[No Abstract] [Full Text] [Related]
12. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
[No Abstract] [Full Text] [Related]
13. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
Cashman JD; Eaves CJ; Sarris AH; Eaves AC
Blood; 1998 Oct; 92(7):2338-44. PubMed ID: 9746772
[TBL] [Abstract][Full Text] [Related]
14. The biology of normal and neoplastic stem cells in CML.
Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A
Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
Ferrajoli A; Talpaz M; Zipf TF; Hirsch-Ginsberg C; Estey E; Wolpe SD; Estrov Z
Leukemia; 1994 May; 8(5):798-805. PubMed ID: 8182937
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic progenitor cell content of bone marrow harvests: relative contributions of blood and bone marrow.
Glasser L; Fiederlein RL; Wood M; Dalton WS; List A
Prog Clin Biol Res; 1994; 389():621-30. PubMed ID: 7700928
[No Abstract] [Full Text] [Related]
17. Purging of acute lymphoblastic leukemia by long-term marrow culture.
Douay L; Ozsahin H; Barbu V; Fabrega S; Giarratana MC; Da WM; Allieri A; Gorin NC
Prog Clin Biol Res; 1992; 377():205-13; discussion 214. PubMed ID: 1438417
[No Abstract] [Full Text] [Related]
18. BCR/ABL-negative clonogenic hematopoietic cells do not accumulate in the plastic-adherent fraction of peripheral blood mononuclear cells from patients with chronic myeloid leukemia in stable chronic phase.
Schultheis B; Pasternak G; Hehlmann R
Folia Biol (Praha); 2000; 46(6):256-63. PubMed ID: 11140859
[TBL] [Abstract][Full Text] [Related]
19. [Effect of macrophage inflammatory protein-1 alpha (MIP-1 alpha) on human erythropoiesis in vitro--clinical implications].
Ratajczak J; Halasa M; Ratajczak MZ
Acta Haematol Pol; 1995; 26(2):171-7. PubMed ID: 7653222
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha-IFN on chronic myeloid leukemia (CML) hematopoiesis maintained in long-term cultures.
Santucci MA; Zuffa E; Russo D; Testoni N; Buzzi M; Baccarani M; Tura S
Bone Marrow Transplant; 1991; 7 Suppl 2():25. PubMed ID: 1878701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
